Cerenome is trading at $1.78, up 7.2%, with no confirmed direct catalyst for the move.
- The rise has continued after the October 27 close; live volume is unavailable.
- On October 27, Cerenome announced it will present interim clinical data on October 29. A Q3 earnings preview also points to an expected October 29 report, but neither establishes a direct reason for the move.
- The press-release page shows no October 28 announcement, and the broad market is mixed.